Trial Profile
A phase I/II study of HuMax-IL8 in patients with palmoplantar pustulosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs HuMax IL8 (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- 27 Oct 2015 New trial record